Publications | Lund University Publications

31 – 40 of 74

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=issn+exact+%221462-8902%22&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
3
4
5
6
…
8
next »

2013
Mark Sitagliptin and pioglitazone provide complementary effects on postprandial glucose and pancreatic islet cell function
Alba, M. ; Ahrén, Bo ^LU ; Inzucchi, S. E. ; Guan, Y. ; Mallick, M. ; Xu, L. ; O'Neill, E. A. ; Williams-Herman, D. E. ; Kaufman, K. D. and Goldstein, B. J. (2013) In Diabetes, Obesity and Metabolism 15(12). p.1101-1110
- Contribution to journal › Article
Mark Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trials
Monami, M. ; Ahrén, Bo ^LU ; Dicembrini, I. and Mannucci, E. (2013) In Diabetes, Obesity and Metabolism 15(2). p.112-120
- Contribution to journal › Article
Mark Shifting the paradigm of islet inflammation-good guy or bad guy?
Ahrén, Bo ^LU ; Accili, D ; Boitard, C ; Cerasi, E ; Thorens, B and Seino, S (2013) In Diabetes, Obesity and Metabolism 15. p.4-9
- Contribution to journal › Debate/Note/Editorial
Mark Glucose-lowering effect of the DPP-4 inhibitor sitagliptin after glucose and non-glucose macronutrient ingestion in non-diabetic subjects.
Ohlsson, Lena ^LU ; Alsalim, Wathik ^LU ; Carr, Richard D ; Tura, Andrea ; Pacini, Giovanni ; Mari, Andrea and Ahrén, Bo ^LU (2013) In Diabetes, Obesity and Metabolism 15(6). p.531-537
- Contribution to journal › Article
Mark Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 study
Nauck, M. ; Frid, Anders ^LU ; Hermansen, K. ; Thomsen, A. B. ; During, M. ; Shah, N. ; Tankova, T. ; Mitha, I. and Matthews, D. R. (2013) In Diabetes, Obesity and Metabolism 15(3). p.204-212
- Contribution to journal › Article
2012
Mark Pancreatic β-cell dysfunction, expression of iNOS and the effect of phosphodiesterase inhibitors in human pancreatic islets of type 2 diabetes.
Jabar Muhammed, Sarheed ^LU ; Lundquist, Ingmar ^LU and Salehi, S Albert ^LU (2012) In Diabetes, Obesity and Metabolism 14(11). p.1010-1019
- Contribution to journal › Article
Mark Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis.
Deacon, C F ; Mannucci, E and Ahrén, Bo ^LU (2012) In Diabetes, Obesity and Metabolism 14(8). p.762-767
- Contribution to journal › Article
Mark The hyperstimulated beta-cell: prelude to diabetes?
Boitard, Christian ; Accili, Domenico ; Ahrén, Bo ^LU ; Cerasi, Erol ; Seino, Susumu and Thorens, Bernard (2012) In Diabetes, Obesity and Metabolism 14(S3).
- Contribution to journal › Debate/Note/Editorial
Mark Using albumin to improve the therapeutic properties of diabetes treatments.
Ahrén, Bo ^LU and Burke, B (2012) In Diabetes, Obesity and Metabolism 14. p.121-129
- Contribution to journal › Article
2011
Mark Editorial: Long in the shade, glucagon re-occupies centre court
Henquin, J. -C. ; Accili, D. ; Ahrén, Bo ^LU ; Boitard, C. ; Seino, S. and Cerasi, E. (2011) In Diabetes, Obesity and Metabolism 13(Suppl. 1).
- Contribution to journal › Debate/Note/Editorial

« previous
1
…
3
4
5
6
…
8
next »

your query:: Remove issn: 1462-8902